Chi-Che, H., Kuan-Hung, L., Chih-Cheng, L., Wen-Wen, T., & Kuan-Hsien, L. (2026). Catheter ablation and risk of major adverse cardiovascular events in high-risk patients with newly diagnosed atrial fibrillation: a target trial emulation.. Heart (British Cardiac Society).
Chi-Che H, Kuan-Hung L, Chih-Cheng L, Wen-Wen T, Kuan-Hsien L. Catheter ablation and risk of major adverse cardiovascular events in high-risk patients with newly diagnosed atrial fibrillation: a target trial emulation.. Heart (British Cardiac Society). 2026; PMID: 42103456
Chi-Che H, Kuan-Hung L, Chih-Cheng L, et al. Catheter ablation and risk of major adverse cardiovascular events in high-risk patients with newly diagnosed atrial fibrillation: a target trial emulation.[J]. Heart (British Cardiac Society). 2026.
@article{chiche2026,
author = {Ho Chi-Che and Lin Kuan-Hung and Lai Chih-Cheng and Tsai Wen-Wen and Lu Kuan-Hsien},
title = {Catheter ablation and risk of major adverse cardiovascular events in high-risk patients with newly diagnosed atrial fibrillation: a target trial emulation.},
journal = {Heart (British Cardiac Society)},
year = {2026},
note = {PMID: 42103456},
}
TY - JOUR AU - Ho Chi-Che AU - Lin Kuan-Hung AU - Lai Chih-Cheng AU - Tsai Wen-Wen AU - Lu Kuan-Hsien TI - Catheter ablation and risk of major adverse cardiovascular events in high-risk patients with newly diagnosed atrial fibrillation: a target trial emulation. T2 - Heart (British Cardiac Society) PY - 2026 AN - PMID:42103456 ER -
Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure and mortality. While catheter ablation is increasingly used for early rhythm control, evidence on its cardiovascular outcomes in high-risk individuals with newly diagnosed AF remains limited. This study aimed to evaluate the association between catheter ablation and the risk of major adverse cardiovascular events (MACE) in high-risk patients with newly diagnosed AF using a target trial emulation design.